MARKET WIRETradingView • 17h ago
Nutriband Inc. Estimates – NASDAQ:NTRBTradingView report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
Why NTRB Stock dropped -5.12% Today — RQD Quant Desk Flash
$6.30 -5.12% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $6.23
Nutriband Inc. (NTRB) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $76.6M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on NTRB Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is NTRB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Nutriband Inc. (NASDAQ: NTRB) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $6.30 (-5.12% 1D, market cap $76.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NTRB ranks #540 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does NTRB compare to CNXU and LAKE in the Health Care sector?
▼
Within the Health Care sector (Industrial Specialties), NTRB carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 27.8%, and ROIC of -35.0%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $77.0M) and LAKE (Lakeland Industries Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -9.5%, cap $87.3M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for NTRB?
▼
Per NTRB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0001676047), Nutriband Inc. generated $2.0M in revenue (-4.8% YoY), -$8.2M in net income, and -$5.1M in free cash flow against $7.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $6.23 (-1.11%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-9.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NTRB)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (37/100 Composite)
🔍 WHY NTRB SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (30% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▲ #2 Bullish Driver: Whale & Options Positioning+10/20 pts (27% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$6.52-10.3% Next Q
45
Q2 (-2Q)Grade D$5.85+1.7% Next Q
42
Q3 (-1Q)Grade D$5.95+5.9% Next Q
40
CurrentGrade D-$6.30-8.1% Hist 90D α
37
Trajectory: D (45) → D- (37)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a NTRB Turnaround Squeeze
While NTRB currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.42) and Max Pain ($6.62) forces dealer call-delta covering toward $9.65.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $NTRB• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “NTRB Beats Next Quarter EPS Consensus (Jan 30, 2027) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why NTRB Stock dropped -5.12% Today — RQD Quant Desk Flash
Nutriband Inc. (NTRB) dropped -5.12% to $6.30, trading at 55% of its 52-week range ($2.8 – $9.19). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 55% of its 52-week range ($2.8 – $9.19) with RSI-14 at 49.5 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $6.30 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 27.8% gross margin and $0 annual free cash flow.
Live NTRB Headlines & Catalysts
MARKET WIREYahoo! Finance Canada • 20h ago
Nutriband Inc. (NTRB) Seasonal Returns ChartYahoo! Finance Canada report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREGlobeNewswire • 23h ago
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274GlobeNewswire report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
RISK WATCHStock Traders Daily • 1d ago
(NTRB) Risk Channels and Responsive AllocationStock Traders Daily report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Traders Daily • 1d ago
The Technical Signals Behind (NTRB) That Institutions FollowStock Traders Daily report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
RISK WATCHwww.siam.in • 1d ago
Nutriband Warrant (NTRBW) Sinks 68.21% to $0.55 as Leverage Cuts Both Ways - Call Dominatedwww.siam.in report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREGlobeNewswire • 1d ago
Nutriband Files New Patent Application to StrengthenGlobeNewswire report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
CATALYSThttps://www.dars.gov.et/ • 1d ago
NTRB Q3 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus by a Wide Margin - Earnings Decline Riskhttps://www.dars.gov.et/ report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NTRB)
- ✓Walkthrough of NTRB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
NTRB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +70.27%📐 HORIZONTAL RANGE
2026-11-03O $6.64H $6.64L $6.30C $6.30VOL 22.2K
RES: $11.00SUP: $2.60SMA50: $6.42SMA200: $4.39
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
NTRB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -4.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on NTRB today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for NTRB. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for NTRB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NTRB)
Health Care Rank #540 of 1016
⚔️ CNXU vs NTRB Full Matrix →
1. Head-to-Head Health Care Peer Comparison (NTRB vs. CNXU, LAKE, AGPU, APT)
Industry: Industrial Specialties (55 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Nutriband Inc. (NTRB) ranks #540 by composite RQD confidence (37/100, grade D-) and #686 by equity capitalization ($76.6M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with NTRB at 37/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NTRB
ACTIVE
Nutriband Inc. | D- | 37/100 | — | 27.8% | -35.0% | -5.12% | $76.6M | Benchmark Subject |
| CNXU Conexeu Sciences Inc. | D- | 43/100 | — | — | — | -10.25% | $77.0M | /cnxu-vs-ntrb → |
| LAKE Lakeland Industries Inc. | E | 26/100 | — | 32.9% | -9.5% | -1.01% | $87.3M | /lake-vs-ntrb → |
| AGPU Axe Compute Inc. | D- | 42/100 | — | — | -35.0% | -8.78% | $92.7M | /agpu-vs-ntrb → |
| APT Alpha Pro Tech Ltd. | C- | 61/100 | 16.2x | 38.1% | 6.7% | -2.70% | $55.1M | /apt-vs-ntrb → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-01-31 • CIK 0001676047In its most recent audited fiscal period (FY2025, filed 2026-01-31), Nutriband Inc. (NTRB) reported GAAP revenue of $2.0M (-4.8% vs. FY2024 revenue of $2.1M , and -2.3% cumulative change since FY2023) , GAAP net income of -$8.2M, operating cash flow of -$5.1M, and free cash flow of -$5.1M (-8.9% YoY). On the balance sheet, NTRB closed FY2025 with $7.5M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-01-31 | $2.0M | -$8.2M | -$5.1M | -$5.1M | $7.5M | — |
| FY2024 (FY) | 2025-01-31 | $2.1M | -$10.5M | -$4.6M | -$4.7M | $7.5M | — |
| FY2023 (FY) | 2024-01-31 | $2.1M | -$5.5M | -$3.5M | -$3.5M | — | — |
3. NTRB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs NTRB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Nutriband Inc. (NASDAQ: NTRB) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $6.30 (-5.12% 1D, market cap $76.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NTRB ranks #540 in composite RQD confidence.
How does NTRB compare to CNXU and LAKE in the Health Care sector?
Within the Health Care sector (Industrial Specialties), NTRB carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 27.8%, and ROIC of -35.0%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $77.0M) and LAKE (Lakeland Industries Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -9.5%, cap $87.3M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for NTRB?
Per NTRB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0001676047), Nutriband Inc. generated $2.0M in revenue (-4.8% YoY), -$8.2M in net income, and -$5.1M in free cash flow against $7.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is NTRB trading relative to its 50-day, 200-day, and 52-week technical levels?
NTRB last traded at $6.30 (-5.12% on volume of 22,244 shares), positioning the stock -1.87% below its 50-day simple moving average ($6.42) and +43.51% above its 200-day simple moving average ($4.39). Across its 52-week range of $2.80 to $9.19, NTRB sits at the 54.8% percentile with a 14-day RSI of 49.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($5.51 to $7.09).
NTRB Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is NTRB stock moving today?
Why NTRB Stock dropped -5.12% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 37/100 (D-)
✓ STAGE-C NUMBER FIREWALL VERIFIED
NTRB — Nutriband Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:45:00Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, NTRB scores 39 out of 100, earning a letter grade of D- and the verdict label "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are: Fundamental Cash Engine at 4 of 20 (ROIC of -35%; FCF yield of -6.37%), Whale 13F Flow at 11 of 20 (institutional accumulation and options positioning), Insider Conviction at 3 of 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 10 of 20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 11 of 20 (Altman Z 2.5; Piotroski F 4/9; Debt/Equity 0.5).
For a prospective investor, the weakest pillars are the cash engine and insider conviction. A negative ROIC and negative FCF yield indicate the business is not currently generating returns on invested capital or free cash flow, so any upside case depends on operating improvement that the source data does not show. The Forensic Balance Sheet pillar sits in a middle range, which suggests the company is not in acute distress on the metrics provided but is not in a strong position either. The insider pillar, scored low, indicates limited evidence of insider conviction in the source data. Upside drivers would need to come from a turnaround in profitability or a shift in institutional positioning; valuation tradeoffs are difficult to assess because earnings-based multiples are not available in source data. This is an analytical summary, not personalized financial advice.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $2.0M | $-8.3M | $-8.2M | N/A | $-5.1M | $4.6M | N/A |
| FY 2024 | $2.1M | $-10.3M | $-10.5M | N/A | $-4.7M | $4.3M | N/A |
| FY 2023 | $2.1M | $-4.9M | $-5.5M | N/A | $-3.5M | N/A | N/A |
Per the SEC financials, revenue has been roughly flat across the three reported periods while operating losses are substantial relative to revenue. Per the market data, gross margin is 27.8%, while operating and net margins are both -60% and ROIC is -35%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 4 of 9, and Debt/Equity is 0.5. Cash is reported at $4.6M for FY 2025, but debt is not available in source data.
Recent Catalysts & News Wire Analysis
Per the recent news and catalysts section:
- Warrant exercise: A GlobeNewswire report describes an announcement of warrant exercises at $6.43 for gross proceeds of $1,753,274, which would be a financing-related item.
- Warrant price decline: A report notes the Nutriband Warrant (NTRBW) fell 68.21% to $0.55, flagged as a RED risk-watch item.
- Risk Channels: A Stock Traders Daily item titled around risk channels and responsive allocation is flagged RED on the risk-watch list.
- Market-wire items: Several TradingView, Yahoo! Finance Canada, and Stock Traders Daily reports are flagged YELLOW as market-wire coverage without specific fundamental detail.
Per the Butterfly Supply-Chain Graph, no supply chain is mapped (supply_chain: NONE), with no butterfly links and no proprietary signals.
Open Questions
- What specific products or services generate the $2.0M in FY 2025 revenue, and who are the customers?
- What is the total debt balance, given that debt is listed as N/A across all reported periods?
- What is the basis for the $4.6M cash balance and how long does it fund the reported FCF burn of $-5.1M?
- What drove the warrant exercise at $6.43 and what is the dilution impact on shareholders?
- Who are the institutional holders and insiders, given that the holders section is empty?
NTRB Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Nutriband Inc. (NTRB) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE TradingView • 17h ago
Nutriband Inc. Estimates – NASDAQ:NTRB TradingView report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo! Finance Canada • 20h ago
Nutriband Inc. (NTRB) Seasonal Returns Chart Yahoo! Finance Canada report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE GlobeNewswire • 23h ago
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274 GlobeNewswire report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Stock Traders Daily • 1d ago
(NTRB) Risk Channels and Responsive Allocation Stock Traders Daily report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Traders Daily • 1d ago
The Technical Signals Behind (NTRB) That Institutions Follow Stock Traders Daily report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH www.siam.in • 1d ago
Nutriband Warrant (NTRBW) Sinks 68.21% to $0.55 as Leverage Cuts Both Ways - Call Dominated www.siam.in report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE GlobeNewswire • 1d ago
Nutriband Files New Patent Application to Strengthen GlobeNewswire report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST https://www.dars.gov.et/ • 1d ago
NTRB Q3 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus by a Wide Margin - Earnings Decline Risk https://www.dars.gov.et/ report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
NTRB Bull vs. Bear Conversation Board — What's Your Call at $6.30?
🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON NTRB 🐻 67% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH
🎯 Target: $5.84 (-12.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is NTRB (D- • RQD 39/100) a Buy at $6.64?
Welcome to the NTRB (Nutriband Inc.) Roar Pit. Current RQD Composite is 39/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Industrial Specialties. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
RE RedlineAuditor Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $5.31 (-20.0%)
Spot @ $6.64 Pump the brakes on NTRB — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on NTRB, but look at what you are paying: current EV/EBITDA multiples with 27.8% gross margins. Unless Nutriband Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH
🎯 Target: $8.50 (+28.0%)
Spot @ $6.64 NTRB cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on NTRB, the market is fixating on short-term headline noise in Industrial Specialties and ignoring the balance sheet and cash flow trajectory. At $6.64 (52-wk range $2.80 - $9.19), any beat on forward guidance forces shorts and underweight funds to chase.